NCT06741410

Brief Summary

The study is designed to compare two strategies used in the management of hypotension caused by spinal anesthesia for cesarean section: intravenous phenylephrine given as prophylactic infusion and interventional boluses of intravenous ephedrine. Phenylephrine is currently recommended for battling spinal anesthesia - related sympathectomy, due to some scientific data on possible negative effects of ephedrine on fetal wellbeing. Therefore this study will retrospectively compare both clinical and laboratory data of the newborns delivered by cesarean section where either large dose of ephedrine or continuous infusion of phenylephrine was used for management of hypotension

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

December 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2025

Completed
Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

December 11, 2024

Last Update Submit

September 18, 2025

Conditions

Keywords

cesarean deliveryspinal anesthesiaphenylephrineephedrinehypotension

Outcome Measures

Primary Outcomes (2)

  • Umbilical blood pH

    Sets of data will be tested for normality and standard statistical tests (Student's t - test or Mann - Whitney U - test) will be used to detect the differences in umbilical blood pH between the groups.

    During delivery (from spinal injection to umbilical clamping and cutting)

  • Umbilical blood Base Excess (BE)

    Sets of data will be tested for normality and standard statistical tests (Student's t - test or Mann - Whitney U - test) will be used to detect the differences in umbilical blood Base Excess (BE) between the groups.

    During delivery (from spinal injection to umbilical clamping and cutting)

Secondary Outcomes (1)

  • Hemodynamic stability

    During delivery (from spinal injection to umbilical clamping and cutting)

Study Arms (2)

Ephedrine

Cesarean delivery cases where spinal block was administered and hypotension was managed with intravenous ephedrine. Hospital electronic database will be searched to identify cases of cesarean delivery in years 2020 - 2022. After that, manual review of the medical notes will follow in order to extract cases where spinal block was administered and ephedrine was used to treat spinal - related hypotension. Further chart analysis will yield demographic and hemodynamic data of the parturient, as well as clinical data of the neonate (weight, gender, Apgar score). Further laboratory data on neonatal acid - base status will be acquired from hospital's laboratory electronic database. Attention will be paid to assure that identification of the patients would not be possible using data acquired for the study. All data will be anonymized and accessible only for investigators.

Drug: Ephedrine

Phenylephrine

Cesarean delivery cases where spinal block was administered and hypotension was managed with intravenous phenylephrine infusion Hospital electronic database will be searched to identify cases of cesarean delivery in years 2020 - 2022. After that, manual review of the medical notes will follow in order to extract cases where spinal block was administered and infusion of phenylephrine was used to treat spinal - related hypotension. Further chart analysis will yield demographic and hemodynamic data of the parturient, as well as clinical data of the neonate (weight, gender, Apgar score). Further laboratory data on neonatal acid - base status will be acquired from hospital's laboratory electronic database. Attention will be paid to assure that identification of the patients would not be possible using data acquired for the study. All data will be anonymized and accessible only for investigators.

Drug: Phenylephrine

Interventions

Intravenous boluses of ephedrine

Ephedrine

Intravenous continuous infusion of phenylephrine

Phenylephrine

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Initial cohort of patients will consist of selected cases of cesarean deliveries from Orlowski Hospital in years 2020 - 2022, Department of Obstetrics and Gynaecology, Warsaw, Poland. Intention is to include 40 cases in each group.

You may qualify if:

  • Cesarean delivery at term under spinal anesthesia
  • American Society of Anesthesiologists (ASA) physical status \<3
  • BMI \<40
  • Preemptive phenylephrine infusion or ephedrine boluses used during surgical procedure

You may not qualify if:

  • No vasoconstrictor (phenylephrine nor ephedrine) used throughout the procedure
  • Total dose of ephedrine less than 15mg
  • poor quality of anesthetic record - data required for analysis not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care

Warsaw, 01-813, Poland

Location

Related Publications (3)

  • Ngan Kee WD, Khaw KS, Tan PE, Ng FF, Karmakar MK. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology. 2009 Sep;111(3):506-12. doi: 10.1097/ALN.0b013e3181b160a3.

    PMID: 19672175BACKGROUND
  • Higgins N, Fitzgerald PC, van Dyk D, Dyer RA, Rodriguez N, McCarthy RJ, Wong CA. The Effect of Prophylactic Phenylephrine and Ephedrine Infusions on Umbilical Artery Blood pH in Women With Preeclampsia Undergoing Cesarean Delivery With Spinal Anesthesia: A Randomized, Double-Blind Trial. Anesth Analg. 2018 Jun;126(6):1999-2006. doi: 10.1213/ANE.0000000000002524.

    PMID: 28953494BACKGROUND
  • Mohta M, Aggarwal M, Sethi AK, Harisinghani P, Guleria K. Randomized double-blind comparison of ephedrine and phenylephrine for management of post-spinal hypotension in potential fetal compromise. Int J Obstet Anesth. 2016 Aug;27:32-40. doi: 10.1016/j.ijoa.2016.02.004. Epub 2016 Feb 21.

    PMID: 27020488BACKGROUND

MeSH Terms

Conditions

Hypotension

Interventions

EphedrinePhenylephrine

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

PropanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsPropanolsAminesPhenethylaminesEthylaminesEthanolamines

Study Officials

  • Małgorzata Malec-Milewska, MD, Prof.

    Department of Anesthesia and Intensive Care, Orlowski Hospital, Warsaw

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 11, 2024

First Posted

December 19, 2024

Study Start

December 16, 2024

Primary Completion

September 16, 2025

Study Completion

September 16, 2025

Last Updated

September 19, 2025

Record last verified: 2025-09

Locations